US Stock MarketDetailed Quotes

TNXP Tonix Pharmaceuticals

Watchlist
  • 0.2405
  • +0.0116+5.07%
Close Dec 13 16:00 ET
  • 0.2860
  • +0.0455+18.92%
Post 20:02 ET
44.95MMarket Cap0.00P/E (TTM)

About Tonix Pharmaceuticals Company

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Company Profile

SymbolTNXP
Company NameTonix Pharmaceuticals
Listing DateAug 9, 2013
Founded2007
CEODr. Seth Lederman, M.D.
MarketNASDAQ
Employees103
Fiscal Year Ends12-31
Address26 Main Street,Suite 101
CityChatham
ProvinceNew Jersey
CountryUnited States of America
Zip Code07928
Phone1-862-799-8599

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Seth Lederman, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 2.05M
  • Bradley Saenger, C.P.A.
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 904.91K
  • Jessica Edgar Morris
  • Chief Operating Officer
  • 928.60K
  • Dr. Gregory M. Sullivan, M.D.
  • Chief Medical Officer and Secretary
  • 952.00K
  • Carolyn E. Taylor
  • Independent Director
  • 82.48K
  • Richard Newcomb Stillwell
  • Independent Director
  • 113.05K
  • Richard H. Bagger
  • Independent Director
  • 82.48K
  • James Treco
  • Lead Independent Director
  • 102.48K
  • General David L. Grange
  • Independent Director
  • 82.48K
  • Margaret Smith Bell
  • Independent Director
  • 82.48K
  • Dr. Adeoye Y. Olukotun, M.D.
  • Independent Director
  • 82.48K
Heat List
US
Overall
Symbol
Price
% Chg

No Data